<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04945577</url>
  </required_header>
  <id_info>
    <org_study_id>Gulcanozturk</org_study_id>
    <nct_id>NCT04945577</nct_id>
  </id_info>
  <brief_title>The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection</brief_title>
  <official_title>The Relationship Between Vitamin D Levels, Inflammatory Parameters and Disease Severity of COVID-19 Infection: A Retrospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fatih Sultan Mehmet Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fatih Sultan Mehmet Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Vitamin D deficiency increases the susceptibility to respiratory virus infections and the&#xD;
      severity of infections. Inflammation plays a key role in pathogenesis in COVID19 while&#xD;
      identifying clinical course and prognosis COVID19.The aim of this study was to determine the&#xD;
      relationship between 25OH vitamin D levels, inflammatory laboratory parameters of neutrophil&#xD;
      to lymphocyte ratio (NLR), platelet to lymphocyte ratio (PLR), C-reactive protein (CRP)&#xD;
      levels and disease severity of COVID19 infection.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this retrospective study 300 patients diagnosed with COVID19 were included. According to&#xD;
      clinical classification of cases with COVID19 the patients were divided into three groups;&#xD;
      mild (Group1), moderate (Group2) and severe/critical (Group3). The 25OH vitamin D values&#xD;
      below 20 ng/ml were defined as deficiency, 21-29 ng/ml were defined as insufficiency, and 30&#xD;
      ng/ml and above were defined as normal. Patients' age, gender, comorbid diseases and&#xD;
      laboratory values were recorded&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">August 1, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>25-OH vitamin D</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of ng/ml</description>
  </primary_outcome>
  <primary_outcome>
    <measure>White blood cell count</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of x103/uL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil count</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of x103/uL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil ratio</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lymphocyte count</measure>
    <time_frame>1 day</time_frame>
    <description>x103/uL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lymphocyte ratio</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>platelet count</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of x103/uL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hemoglobin count</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of g/dl</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-reactive protein levels</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of mg/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>neutrophil to lymphocyte ratio</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of %</description>
  </primary_outcome>
  <primary_outcome>
    <measure>platelet to lymphocyte ratio</measure>
    <time_frame>1 day</time_frame>
    <description>laboratory measurement in unit of %</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Actual">300</enrollment>
  <condition>Vitamin D Deficiency</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>Experimental: Mild Clinical Group</arm_group_label>
    <description>patients showing mild clinical symptoms without pneumonia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: Moderate Clinical Group</arm_group_label>
    <description>patients with fever, other respiratory symptoms, and pneumonia findings based on radiological imaging</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Experimental: severe/critical clinical group</arm_group_label>
    <description>severe one of these as follows; patients with hypoxia (≤93% oxygen saturation), respiratory distress (RR &gt;30 times per minute), partial pressure of arterial blood oxygen (PaO 2 )/the fraction of inspired oxygen (FiO 2 ) ≤ 300 mmHg, patients whose chest imaging shows that lung damage develops significantly within 24 to 48 hours, or critical one of these as follows; respiratory failure requiring mechanical ventilation, signs of septic shock with multiple organ failure requiring intensive care unit admission.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Inflammatory Parameters</intervention_name>
    <description>Laboratory measurement of patient's inflammatory status in unit of % and mg/dl</description>
    <arm_group_label>Experimental: Mild Clinical Group</arm_group_label>
    <arm_group_label>Experimental: Moderate Clinical Group</arm_group_label>
    <arm_group_label>Experimental: severe/critical clinical group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>25 OH Vitamin D Level</intervention_name>
    <description>Laboratory measurement of patient's 25 OH vitamin D level in unit of ng/dl</description>
    <arm_group_label>Experimental: Mild Clinical Group</arm_group_label>
    <arm_group_label>Experimental: Moderate Clinical Group</arm_group_label>
    <arm_group_label>Experimental: severe/critical clinical group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        COVID19 infection positive patients whose polymerase chain reaction (PCR) test positive&#xD;
        patients and whose 25-OH vitamin D levels were measured in the last 6 months&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  The study included 300 polymerase chain reaction (PCR) test positive patients and&#xD;
             whose 25-OH vitamin D levels were measured in the last 6 months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with COVID-19 whose 25-OH vitamin D levels were not measured in the last 6&#xD;
             months before the COVID-19 diagnosis were excluded from the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>97 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Gulcan Ozturk</name>
      <address>
        <city>Istanbul</city>
        <zip>34752</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Ali N. Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19. J Med Virol. 2020 Nov;92(11):2409-2411. doi: 10.1002/jmv.26097. Epub 2020 Jun 9.</citation>
    <PMID>32516845</PMID>
  </reference>
  <reference>
    <citation>Ali N. Role of vitamin D in preventing of COVID-19 infection, progression and severity. J Infect Public Health. 2020 Oct;13(10):1373-1380. doi: 10.1016/j.jiph.2020.06.021. Epub 2020 Jun 20. Review.</citation>
    <PMID>32605780</PMID>
  </reference>
  <reference>
    <citation>Khemka A, Suri A, Singh NK, Bansal SK. Role of Vitamin D Supplementation in Prevention and Treatment of COVID-19. Indian J Clin Biochem. 2020 Jul 30:1-2. doi: 10.1007/s12291-020-00908-3. [Epub ahead of print]</citation>
    <PMID>32837034</PMID>
  </reference>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 6, 2021</study_first_submitted>
  <study_first_submitted_qc>June 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 30, 2021</study_first_posted>
  <last_update_submitted>June 28, 2021</last_update_submitted>
  <last_update_submitted_qc>June 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>COVID-19</keyword>
  <keyword>Vitamin D</keyword>
  <keyword>Disease severity</keyword>
  <keyword>Inflammatory markers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>COVID-19</mesh_term>
    <mesh_term>Vitamin D Deficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin D</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

